Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples